Zacks Research Issues Positive Estimate for PDCO Earnings

Patterson Companies, Inc. (NASDAQ:PDCO) – Equities research analysts at Zacks Research increased their Q4 2025 EPS estimates for shares of Patterson Companies in a report released on Wednesday, March 19th. Zacks Research analyst I. Bandyopadhyay now forecasts that the company will post earnings of $1.11 per share for the quarter, up from their previous estimate of $0.93. The consensus estimate for Patterson Companies’ current full-year earnings is $2.25 per share. Zacks Research also issued estimates for Patterson Companies’ Q3 2026 earnings at $0.61 EPS, Q3 2027 earnings at $0.60 EPS and FY2027 earnings at $2.44 EPS.

A number of other equities analysts have also recently weighed in on PDCO. Piper Sandler lowered their price target on Patterson Companies from $26.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, December 6th. Robert W. Baird increased their target price on shares of Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a research note on Thursday, December 12th. Leerink Partners reissued a “market perform” rating and issued a $31.35 price target (up from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Morgan Stanley increased their price objective on shares of Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Mizuho initiated coverage on Patterson Companies in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $23.00 target price on the stock. Eleven equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $26.57.

Patterson Companies Trading Up 0.1 %

Shares of Patterson Companies stock opened at $31.24 on Monday. The stock has a 50 day moving average of $31.05 and a 200 day moving average of $26.37. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The firm has a market capitalization of $2.76 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 2.71 and a beta of 0.99. Patterson Companies has a fifty-two week low of $19.45 and a fifty-two week high of $31.79.

Institutional Investors Weigh In On Patterson Companies

Several large investors have recently bought and sold shares of the stock. Harbour Investments Inc. acquired a new position in shares of Patterson Companies during the fourth quarter worth about $26,000. Huntington National Bank increased its position in shares of Patterson Companies by 54.0% in the 4th quarter. Huntington National Bank now owns 1,115 shares of the company’s stock valued at $34,000 after purchasing an additional 391 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Patterson Companies by 103.0% in the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company’s stock valued at $41,000 after purchasing an additional 680 shares in the last quarter. Anchor Investment Management LLC lifted its position in shares of Patterson Companies by 20.5% during the 3rd quarter. Anchor Investment Management LLC now owns 2,350 shares of the company’s stock worth $51,000 after purchasing an additional 400 shares during the last quarter. Finally, Quadrant Capital Group LLC increased its holdings in Patterson Companies by 501.6% in the fourth quarter. Quadrant Capital Group LLC now owns 1,883 shares of the company’s stock valued at $58,000 after buying an additional 1,570 shares during the last quarter. Hedge funds and other institutional investors own 85.43% of the company’s stock.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.